Last synced on 6 December 2024 at 11:05 pm

Reagents, 2019-Novel Coronavirus Nucleic Acid

Page Type
Product Code
Definition
Nucleic acid-based in vitro diagnostic devices for the detection of 2019-novel coronavirus (2019-nCoV) and/or diagnosis of 2019-nCoV infection in human clinical specimens.
Physical State
In Vitro Diagnostic Primers, Probes and/or capture oligos.
Technical Method
Nucleic acid amplification and/or detection.
Target Area
The device is an in-vitro diagnostic device; none of the body parts will utilize the device or are intended to be affected by the device.
Review Panel
Microbiology
Submission Type
EUA - Emergency Use Authorization
Device Classification
N
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

No Linked CFR Text

As product code QJR is assigned to devices that are "not-classified", it is not linked to any specific regulation and CFR section.

Reagents, 2019-Novel Coronavirus Nucleic Acid

Page Type
Product Code
Definition
Nucleic acid-based in vitro diagnostic devices for the detection of 2019-novel coronavirus (2019-nCoV) and/or diagnosis of 2019-nCoV infection in human clinical specimens.
Physical State
In Vitro Diagnostic Primers, Probes and/or capture oligos.
Technical Method
Nucleic acid amplification and/or detection.
Target Area
The device is an in-vitro diagnostic device; none of the body parts will utilize the device or are intended to be affected by the device.
Review Panel
Microbiology
Submission Type
EUA - Emergency Use Authorization
Device Classification
N
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

No Linked CFR Text

As product code QJR is assigned to devices that are "not-classified", it is not linked to any specific regulation and CFR section.